APA (7th ed.) Citation

NR, P., T, L., J, I., S, C., TC, S., Z, D., . . . N, C. (2023). Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease. Nature communications, 14(1), 1474. https://doi.org/10.1038/s41467-023-37209-1

Chicago Style (17th ed.) Citation

NR, Powell, et al. "Clinically Important Alterations in Pharmacogene Expression in Histologically Severe Nonalcoholic Fatty Liver Disease." Nature Communications 14, no. 1 (2023): 1474. https://doi.org/10.1038/s41467-023-37209-1.

MLA (9th ed.) Citation

NR, Powell, et al. "Clinically Important Alterations in Pharmacogene Expression in Histologically Severe Nonalcoholic Fatty Liver Disease." Nature Communications, vol. 14, no. 1, 2023, p. 1474, https://doi.org/10.1038/s41467-023-37209-1.